ABSTRACT
INTRODUCTION
Snake venoms are complex combinations of several proteins (mostly enzymes), peptides, nucleotides, free amino acids, biogenic amines, some lipids, and several ions capable of inducing physiopathologies characteristic of each species. Venoms generally produce local effects such as hemorrhage, necrosis, edema and intense pain, and systemic effects such as bleeding disorders, cardiovascular shock and acute renal failure 1 . Snake venoms present different actions that depend on the specific combinations of their components, such as phospholipases A2, serineproteases, metalloproteinases, hyaluronidases and L-amino acid oxidases 2 . Annually, about 40,000 people die of snakebites worldwide, including about 25,000 in India, 10,000 in the United States and the rest in other countries 3 . In Brazil, accidents with snakes of the Bothrops genus (Viperidae), widely distributed throughout the national territory, stand out in number and severity, being of great relevance because of permanent sequels characterized mainly by the loss of the affected limb 4 . The snakes of the Lachesis genus (Viperidae) are also relevant because of the severity of the local effects induced by their venoms, although they have a geographical distribution restricted to the Amazon basin (Lachesis muta muta L.) and the Atlantic forest, from north of Rio de Janeiro to Paraiba (Lachesis muta rhombeata L.) 5 . The search for new inhibitors of isolated toxins and snake venoms is essential to complement or even to replace serotherapy, because this type of therapy is not very effective in neutralizing the local effects observed after snakebites and it is not very accessible to high-risk areas. The popular use of medicinal plants for the treatment of snakebites has been consecrated because they have a broad spectrum of effects 6, 7, 8, 9, 10 . This fact emphasizes the economic and medical importance of ethnopharmacological studies that evaluate the therapeutic properties of plant species. These studies have been exploring the possibility of using plant extracts and isolated active principles for the inhibition of clotting/hemorrhage, inflammation, myotoxicity, edema, and cardiotoxicity, among others. The active components derived from plants usually act as enzyme inhibitors, inactivating chemicals or immunomodulation agents capable of interacting with macromolecules present in the venoms from different species of snakes or with target molecules belonging to the animal organism 7 .
Some of the tests used to evaluate the inhibitory potential of plant compounds against snake venoms are the determination of the effects on blood clotting and fibrinogenolysis. Proteases (serine and metalloproteinases) are the principal enzymes responsible for these activities, being involved in the induction of necrosis and hemorrhage 2, 8, 10, 11, 12, 13 . 13 . In addition, Miranda et al. (2014) 15 reported the inhibitory effect of the essential oil from Hedychium coronarium on fibrinogenolysis and clotting induced by Bothrops and Lachesis snake venoms. The chemical composition of essential oils is characteristic to each species, presenting a biological function vital to the survival and adaptation of the plants to the environment. Even though they are complex mixtures of chemicals, phenylpropanoids and terpenoids predominate in their compositions, and, within this last class, the monoterpenes are the compounds found in greater proportion in essential oils, followed by sesquiterpenes. The combination of constituents of each essential oil is related to its pharmacological properties 16 . Among the plants producing essential oils, the Asteraceae family has been widely explored because it is the largest systematic group of Angiosperms, comprising about 1,100 genera and 25,000 species 17 . Considering the wide applicability of secondary metabolites present in essential oils in pharmaceutical, cosmetic and food sciences, and the scarcity of studies on antiophidian properties, a new and promising line of research to be explored is the pharmacological characterization of these oils with a view to the development of products for the treatment of snakebites. Therefore, the aim of this study was to assess the inhibitory properties of essential oils extracted from the leaves of four species of the Asteraceae family [ The essential oils from fresh leaves were extracted by hydrodistillation using a modified Clevenger apparatus connected to a 4L round-bottomed flask for a period of 2 h 18 . The hidrolacts were centrifuged for 5 minutes at 965g, and the oils were packaged in amber glass bottles and stored at a temperature of 4ºC.
Identification and quantification of the essential oil constituents
The GC-MS analyses was performed using a Perkin Elmer Autosystem XL gas chromatograph equipped with a fused silica DB-1 column (30 m x 0.25 mm ID, film thickness 0.25 m; J & W Scientific Inc.) coupled to a Perkin Elmer Turbomass mass spectrometer (software version 4.1). The oven temperature was programmed from 45 to 175ºC at 3ºC/min and, subsequently, at 15ºC/min to 300ºC, where it was held for 10 min.
The temperature of the transfer line was 280ºC; the temperature of the ionization chamber was 220ºC; the flow rate of the helium carrier gas was 30 cm/s; and the split ratio was 1:40. The identity of the compounds was determined by comparison of their retention indices and mass spectra with those of commercial standards and reference compounds present in oils existing in the laboratory and by comparing the spectra with a library of mass spectra developed in the laboratory of the Centre for Plant Biotechnology of the Faculty of Sciences, University of Lisbon. The essential oils were analyzed by gas-liquid chromatography on a Perkin Elmer model 8700 gas chromatograph equipped with two flame ionization detectors (FID), a system for data processing and an automatic injector. Two columns of different polarity were installed with the following characteristics: DB-1 fused silica methylsilicone immobilized phase (30 m x 0.25 mm ID, film thickness 0.25 m; J & W Scientific Inc.); DB-17HT phenylmethylsilicone immobilized phase (30 m x 0.25 mm id). The oven temperature was programmed from 45ºC to 175ºC at 3ºC/min and, subsequently, at 15ºC/min to 300ºC, where the temperature was maintained for 10 min. The temperatures of the injector and detector were 290ºC and 280ºC, respectively. The flow rate of the hydrogen carrier gas was 30 cm/s, and the split ratio was 1:50. The percentage composition of the oils was determined by integration of peak areas without using correction factors. The values given represent the average of two injections 19, 15, 20 . 
Citrated human plasma

Snake venoms Desiccated Lachesis muta, Bothrops atrox and
Bothrops moojeni venoms were purchased from Bioagents Serpentarium (Batatais, São Paulo, Brazil) and stored at 4ºC until the time for preparation of solutions for use in the biological tests. The venoms were weighed and then dissolved in phosphate-buffered saline solution (PBS).
Effects of the essential oils on clotting -induction or inhibition
The coagulant potential of the essential oils was assessed as previously described (Selistre et al. 1990 ) 21 . Volumes of 200 µL of citrated human plasma were maintained in a water bath at 37ºC, and two different volumes (0.6 and 1.2 µL) of essential oils were added, following by observation and measurement of time. The samples were gently shaken every 5 min for 45 min. The incoagulability was defined as the absence of clotting after 24 h of observation. The inhibitory action of the essential oils on the coagulant activity induced by the venoms was also determined 22 . Pilot tests were performed for each venom to determine the dose necessery to clot 200 µL of citrated plasma at 37ºC withing 40 and 120 seconds (s). Two interacting variables were evaluated: the first predicted the possible interaction between essential oil constituents and blood plasma components; the second considered the possible interaction between essential oil constituents and coagulating toxins present in the venoms. In the first test, prior incubation of the plasma (200 µL) with different volumes of the essential oils (0.6 and 1.2 µL) was performed at 37ºC for 15 min, followed by the addition of 1 µL (10 µg) of each venom solution (L. muta, B. atrox and B. moojeni) separately, and the time required for coagulation was measured. In the second test, different volumes of the essential oils (0.6 and 1.2 µL) were incubated with the snake venoms for 15 min at 37ºC, followed by the addition of plasma (200 µL), and the time required for clot formation was measured.
Fibrinogenolytic and the antifibrinogenolytic activities of the essential oils
These activities were performed according to Czaikoski et al. (2010) 23 . Essential oils (0.6 and 1.2 µL) were incubated with bovine fibrinogen (60 µg) for 1.5 h at 37ºC in a final volume of 25 µL (PBS). 24 . A control sample containing only fibrinogen (60 µg in 25 µL of PBS) was submitted to electrophoresis under the same conditions. The inhibitory potential of the essential oils on the proteolysis induced by L. muta, B. atrox and B. moojeni venoms was assessed by SDS-PAGE [sodium dodecyl sulfate (SDS) polyacrylamide (PAGE)]. The essential oils (0.6 and 1.2 µL) and snake venoms (30 µg) were pre incubated for 30 min at 37ºC at first, followed by addition of fibrinogen molecules (60 µg) and subsequent incubation for an additional 1.5 h. In another assay, the essential oils and fibrinogen molecules were incubated for 30 min at 37ºC, followed by addition of snake venoms and subsequent incubation for an additional 1.5 h.
Statistical Analysis
The experimental designs used for the clotting inhibition tests were completely randomized blocks in 2 x 4 factorial schemes (2 concentrations x 4 essential oils), with three repetitions. The essential oils were compared with one another because they were extracted from species of the same botanical family. The significant factors determined by the Test F (p < 0.05) were subjected to the Scott-Knott Test of means (5%) for determination of the models. The data were analyzed using the statistical program Sisvar 25 .
RESULTS AND DISCUSSION
The essential oils are mixtures of numerous compounds, with one or two major constituents, and their biological activities can be attributed to a synergic action among the molecules 16 . The variability in the constitution of essential oils is directly related to the species, and, within the same species, several factors can affect the composition, such as chemotype, location, collection period, and vegetative cycle, among others 26 . Considering the plant species used in this study the major constituents of the essential oils from fresh leaves of B. dracunculifolia are limonene (30.9%), transnerolidol (22.4%) and β-pinene (14.5%), while those in the oil from C. bonariensis were limonene (56.7%), trans-β-ocimene (26.3%) and cisverbenol (4.4%). The oil from T. diversifolia contained β-pinene (38.3%), α-pinene (28.6%) and limonene (8.8%) as the principal constituents 20 , and the main compounds found in the oil from A. 20, 15 . Among the pharmacological potentials, the antiophidian properties of the essential oils and its constituints from species of the Asteraceae family were partially evaluated in this work, for the first time. There is no mention of these essential oils in literature regarding their antiophidian properties. Snakebites represent a public health problem in Brazil, and the search for natural compounds that act effectively in neutralizing the local effects induced by toxins are of fundamental importance 27 since the traditional antivenom has low effectiveness in counteracting local effects. The essential oils (0.6 and 1.2 µL) assessed showed no clotting activity over a 24 h period. After prior incubation of venoms and oils, the clotting times (CT) obtained for L. muta and B. moojeni venoms increased significantly in the presence of all the essential oils ( For each venom analyzed, the means followed by the same letter (uppercase for comparisons between essential oils and lower case for comparison of the concentrations), do not differ significantly at the 5% probability by Scott-Knott Test. *The previous incubations, containing oils and venoms, were performed for 15 min at 37ºC, followed by the addition of plasma and measurement of time. 28 . Previous incubation of the extract with the venom in different proportions (w/w) resulted in partial inhibition of clotting and 100% inhibition at a ratio of 1:200 (w/w). The extract of this plant was considered to be a promising source of natural inhibitors of serine proteases, the main enzymes involved in clotting disorders induced by snake venoms. In the present study, the inhibitory effect was observed for all the essential oils. The partial inhibitory effect observed for the oils can be related to the volumes employed, which were lower than those generally used in the tests involving aqueous extracts because of limitations of the method to the use of low-polarity compositions. The venoms from L. muta, B. moojeni and B. atrox have different constitutions and, consequently, possess different mechanisms of action. However, all of them act on the blood clotting cascade, inducing clotting in the absence of calcium mainly due to the action of serineproteases 29, 5 . Studies of the composition of all the essential oils evaluated demonstrated the presence of only terpenes, with individual variations in the contents of monoterpenes and sesquiterpenes 15, 20 . The results obtained showed that the clotting induced by the venoms was inhibited largely by the essential oil from C. bonariensis, which has the highest content of monoterpenes (92.2%) among the essential oils evaluated, indicating these compounds as potential enzyme inhibitors. Tests employing prior incubation of the oils with plasma and subsequent addition of venoms were also conducted ( Table 2 ) and, unlike the first incubation described, all the essential oils accelerated the clotting time induced by L. muta venom. No significant differences in the proclotting effects of B. dracunculifolia, C. bonariensis and A. polystachya were observed, but these effects were statistically lower than those observed for the oil from T. diversifolia. The results suggest that there are interactions of plant compounds not only with snake venom toxins but also with blood plasma constituents which participate in the coagulation cascade. For each venom analyzed, the means followed by the same letter (uppercase for comparisons between essential oils and lower case for comparison of the concentrations), do not differ significantly at the 5% probability by Scott-Knott Test. *The previous incubations, containing oils and venoms, were performed for 15 min at 37ºC, followed by the addition of plasma and measurement of time. 13 observed that the ethanol extract of leaves from Nectandra angustifolia was effective in inhibiting the hemolytic and coagulant activities induced by Bothrops neuwiedi venom, whereas the essential oil from the same plant was only active against the coagulant effect. The authors analyzed the essential oil by GC and GC-MS and found α-pinene, β-pinene and limonene. The same compounds were the predominant molecules in the essential oils evaluated in the present study. Ten ethanol extracts obtained from species belonging to different families inhibited 100% of the defibrinogenation and clotting induced by the B. asper venom when evaluated in vivo 30 . The aqueous extract of leaves from Casearia sylvestris Sw. (Flacourtiaceae) inhibited the proteases of venoms from various Bothrops species, neutralizing the hemorrhagic activity and partially inhibiting the coagutant effect and the proteolytic activity evaluated on the substrates casein and fibrinogen 31 . Although the aqueous extract of Mandevilla velutina has been primarily reported as an inhibitor of phospholipases A2, the inhibitory potential against the hemorrhagic, fibrinogenolytic and caseinolytic activities, attributed mainly to proteases, has also been observed 32 . Thus, it's possible to conclude that plant molecules of different polarities present in extracts and oils interact with the different classes of enzymes present in the venoms, as well as with free molecules and animal cell components to protect them, resulting in partial or total inhibition of local symptoms of snakebites, especially those induced by Bothrops venoms. Althought the potential of plants to inhibit different effects induced by toxins from snake venoms is being widely explored, most research involve extracts highlighting essential oils as mixtures of promising natural compounds to be explored. Compounds isolated from species of Asteraceae with antiophidian properties have also been reported, such as the diterpeneclerodane (Bt-CD) isolated from Baccharis trimera (Less) DC, cynarin from Cynara scolymus L., wedelolactone, sitosterol, stigmasterol, d-mannitol and dimethylwedelolactone from Eclipta prostrate (Linn.) Linn, coumarin from Mikania glomerata (Sprengel), silymarin from Silybum marianum (L.) Gaertn, and caffeic and chromogenic acid derivatives from Vernonia condensata Baker. Although there are reports of proteins and steroids with antiophidian properties, these properties most noticable in phenolic compounds (flavonoids, cumestans, pterocarpans, nitro-compounds, tannic acid and others) and terpenes (mainly diterpenes and triterpenes) 14 .
Mendes et al. (2008)
2 assessed the antiophidian potential of the aqueous extract of Schizolobium parahyba (Vell.) Blake (Family: Fabaceae Caesalpinoideae) and found that the clotting induced by B. pauloensis venom required eight times as long in a 1:50 w/w proportion. However, very weak inhibition was observed when the clotting was induced with C. durissus terrificus venom. In the present study the inhibitory activity of the essential oils against Bothrops venoms was higher than that observed for Crotalus (results not shown), reinforcing the hypothesis of the occurrence of a specific interaction between oil compounds and proteins present in the venoms from different snake species. A variety of synergistic interactions between the molecules could be better exploited in future studies using standards corresponding to major compounds, both separately or in mixtures that simulate the composition of the oils. Fibrinogen is a dimeric glycoprotein of 340 kDa present in the blood. It consists of polypeptide chains (α, β and γ) with molecular weights of 66.5, 52 and 47 kDa, respectively 33 . Fibrinogen molecules have been widely used as substrates to evaluate the proteolytic effect induced by venoms related to hemorrhagic and/or thrombolytic activities, because isolated proteases may be coagulants, anticoagulants or proclotting 34 . These essential oils from B. dracunculifolia, C. bonariensis, T. diversifolia and A. polystachya, previously incubated with fibrinogen solution, did not induce cleavage or differential migration of the fibrinogen chains (α, β and γ) in the analyses performed by polyacrylamide gel electrophoresis. However, some molecules of fibrinogen incubated with the essential oils could have resisted the reduction induced by β-mercaptoethanol and heating at 100ºC for 5 min. On the other hand, samples that have not penetrated the gel may be artifacts of fibrinogen molecules that interacted with constituents of the oils, which could prevent their migration. Some examples of the effect observed during the analysis can be viewed in Figure 1A . L. muta, B. moojeni and B. atrox venoms were used as sources of proteolytic agents to induce principally the cleavage of the alpha chain of fibrinogen molecules ( Figure  1B ). The fibrinogenolytic activity of B. atrox venom was not inhibited by the essential oils from B. dracunculifolia, C. bonariensis, T. diversifolia or A. polystachya. Cintra and coworkers 4 described that Batroxase, a metalloproteinase with high fibrinogenolytic and thrombolytic activities present in the same venom, is probably one of the enzymes responsible for the proteolysis observed, which was not inhibited in the present study 4 . Tests using different volumes of oils, incubation times, run times, concentrations of polyacrylamide in the gel and variations of the staining times in the presence of Coomassie Brilliant Blue (results not shown) resulted in the hypothesis that the fibrinogen molecules could be interacting with constituents of the oils, making it impossible to bind the dye with fibrinogen molecules. Coomassie Brilliant Blue interacts with protein macromolecules containing amino acids side chains with a basic or aromatic character. Several substances can interfere in these interactions, including polyphenols and polyphenol oxidases 35 , which could present binding mechanisms similar to those of the molecules present in the essential oils evaluated in the present work. The fibrinogenolysis induced by L. muta venom was only inhibited when the B. dracunculifolia oil was previously incubated with fibrinogen, with subsequent addition of the venom ( Figure 1B , sample 5). It is suggested that molecules of the sesquiterpene fraction of this oil (36.6%) protect the fibrinogen molecules against the action of proteases present in L. muta venom. The essential oil from A. polystachya proved to be effective in inhibiting the fibrinogenolytic activity induced by B. moojeni venom in trials involving prior incubation with fibrinogen or venom ( Figure  1B, samples 8 and 9, respectively) . The fact that the B. dracunculifolia oil inhibited the activity of L. muta venom, and the oil from A. polystachya only inhibited that of B. moojeni venom, indicates the presence of specific and not random interactions, considering the wide composition range and diversity of homologous proteins present in snake venoms. This hypothesis is in agreement with observations made previously by other authors about plants with antiophidian properties 2 . These observations indicate the possibility that the essential oil components from A. polystachya, mostly sesquiterpenoids (62.7%), connect efficiently with fibrinogen, thereby reducing the fibrinogenolysis induced by the venom. In addition, incubation of A. polystachya with B. moojeni venom and evaluation of the results by SDS-PAGE confirmed the interactions of compounds present in the oils with proteins present in the venoms. Bands with molecular weights corresponding to that of phospholipases A2 were observed after staining, but not those corresponding to proteases (results not shown). A 100% inhibition of the fibrinogenolytic activity of Bothrops venoms was observed by Vale and coworkers, after incubation with an aqueous extract of Shizolobium parahyba 11 . These authors suggested the presence of interactions between tannins and proteins and related that they are influenced by the number of these molecules present in the reaction medium, as well as by the pH and ionic strength of the medium 35 . Thus, future studies evaluating variations in the reaction medium during the incubations of essential oils with snake venoms would make it possible to define more efficiently the mechanisms of these inhibitory effects.
CONCLUSIONS
The compositions of essential oils from C. bonariensis and T. diversifolia, composed predominantly by monoterpenes, are very different from those of the most active essential oils (B. dracunculifolia and A. polystachya). Thus, considering the variations in oil composition and the enzyme composition of the venoms, the changes in the activities evaluated may be related to specific interactions between monoterpenes and sesquiterpenes and proteases from snake venom. Metalloproteases belonging to different classes and presenting distinct structural domains, such as disintegrin and lectin simile, and also serineproteases, are molecules that are possibly involved in interactions with constituents of essential oils.However, the oils evaluated presented some relevant therapeutic properties because they allinhibited the clotting and fibrinogenolysis induced by the venoms.Considering the low degree of effectiveness of traditional serotherapy in the treatment of the local effects induced by snakebites, the essential oils hold promise for topical use as potential inhibitors of venom toxins. The oils, in general, do not require specific pharmaceutical preparations and could have direct applications soon after extraction. Many oils with antimicrobial, anti-inflammatory and healing properties are described in the literature, and these actions are of great value in the treatment of snake envenomations. Further studies on the isolation of constituents of these oils and the elucidation of the mechanisms of interaction between secondary metabolites, venom proteins and animal proteins are essential for the development of new antiophidian therapies and to establish the ideal conditions for the application of essential oils.
